These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 8765506)

  • 1. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR; Bittman R; Peters A; Mayhew E
    J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of the antiproliferative effects of 1-O-hexadecyl-2-O-methyl-3-O-(2'-acetamido-2'-deoxy-beta-D- glucopyranosyl)-sn-glycerol and 1-O-hexadecyl-2-O-methyl-3-0- (2'-amino-2'-deoxy-beta-D-glucopyranosyl)-sn-glycerol on epithelial cancer cell growth.
    Erukulla RK; Zhou X; Samadder P; Arthur G; Bittman R
    J Med Chem; 1996 Mar; 39(7):1545-8. PubMed ID: 8691486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC; Wykle RL; Modest EJ; Daniel LW
    Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E
    Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization.
    Kosano H; Takatani O
    Cancer Res; 1989 Jun; 49(11):2868-70. PubMed ID: 2785846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
    Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
    Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
    Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid.
    Kosano H; Yasutomo Y; Kugai N; Nagata N; Inagaki H; Tanaka S; Takatani O
    Cancer Res; 1990 Jun; 50(11):3172-5. PubMed ID: 2334912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antineoplastic properties of ether-linked thioglycolipids.
    Guivisdalsky PN; Bittman R; Smith Z; Blank ML; Snyder F; Howard S; Salari H
    J Med Chem; 1990 Sep; 33(9):2614-21. PubMed ID: 2391700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro.
    Ashagbley A; Samadder P; Bittman R; Erukulla RK; Byun HS; Arthur G
    Anticancer Res; 1996; 16(4A):1813-8. PubMed ID: 8712705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiproliferative and antiviral activity of carbohydrate-modified pyrrolo[2,3-d]pyridazin-7-one nucleosides.
    Meade EA; Wotring LL; Drach JC; Townsend LB
    J Med Chem; 1997 Feb; 40(5):794-801. PubMed ID: 9057866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
    Kosano H; Takatani O
    Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylated antitumor ether lipids are more effective against oncogene-transformed fibroblasts than alkyllysophospholipids.
    Samadder P; Byun HS; Bittman R; Arthur G
    Anticancer Res; 1998; 18(1A):465-70. PubMed ID: 9568121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA; Buettner GR; Oberley LW; Burns CP
    Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic properties of D-gluco-, D-galacto- and D-manno-configured 2-amino-2-deoxy-glycerolipids against epithelial cancer cell lines and BT-474 breast cancer stem cells.
    Samadder P; Xu Y; Schweizer F; Arthur G
    Eur J Med Chem; 2014 May; 78():225-35. PubMed ID: 24681987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
    Zhou X; Lu X; Arthur G
    Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe modifications of ether- ester- or diester-linked glycerolipid and non glycerolipid synthesis in human neuroblastoma LAN-1 cells cultured with octadecylmethylglycerophosphocholine.
    Boucrot P; Aubry J; Mezazigh A
    Arch Physiol Biochem; 1995 May; 103(2):165-74. PubMed ID: 9338088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
    Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
    J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.